Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4de91344e18ccffba693da1517208d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a55867b6275c06a775126644f711eaa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99846dc1aa30cac78658754457d392ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67943e690cf3c83c9d4f722ebe4a2d77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44df766f7fca9d1c4f11e8e597b09ef1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-195 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
filingDate |
2011-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd0e768a14dae6efce67681879e4cd73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e0bb8cd974dd3b4894956769199922e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b730165caad63255a7718b5cec3445bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26cfe172f51f91868dc3b5ecfb7cd3a1 |
publicationDate |
2011-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011120859-A1 |
titleOfInvention |
Fusion protein and its uses |
abstract |
The present invention relates to a fusion protein comprising a) a first polypeptide selected from among SDF-1 (stromal cell derived factor-1) or peptidase/protease-resistant variants or fragments thereof which have the CXCR4-/CXCR7- binding function of SDF‑1; and b) a second polypeptide which is selected from among GPVI (glycoprotein VI), or the extracellular domain of GPVI, or fragments or variants of the extracellular domain of GPVI which contain the collagen binding function of GPVI where the first polypeptide and the second peptide are linked to one another directly or via a linker molecule. The invention furthermore relates to the use of the fusion protein for treating diseases. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019007959-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3424957-A1 |
priorityDate |
2010-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |